Vaxcyte, Inc. PCVX 深 沪
等待开盘 02-07 09:30:00 美东时间
56.14
+2.230
+4.14%
华盛通- 最 高58.95
- 今 开55.16
- 成交量 45.63万股
- 最 低 43.945
- 昨 收 53.91
- 总市值 327.37万
- 52周最高 58.95
- 市盈率 静 --
- 换手率 782.48%
- 52周最低 0.00
- 委 比 -26.54%
- 总股本 5.83万
- 历史最高 58.95
- 量 比 0.17
- 振 幅 27.83%
- 历史最低 0.00
- 每 手 1
- 风险率 15.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vaxcyte shares are trading lower after the company announced a $500 million offering.
Vaxcyte shares are trading lower after the company announced a $500 million off...
01-30 05:29
Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase
Vaxcyte shares rise after starting Phase 3 trials for its VAX-31 pneumonia vaccine, expanding studies in adults and infants while planning major U.S. manufacturing investments.
01-23 23:12
CDC专家组支持扩大肺炎球菌疫苗接种年龄 辉瑞默沙东市场大扩容
美国疾病控制与预防中心(CDC)的免疫实践咨询委员会(ACIP)以14比1的投票结果推荐将肺炎球菌结合疫苗(PCV)的接种年龄建议降低至50岁及以上的成年人，这一决策可能显著扩大辉瑞(PFE.US)和默沙东(MRK.US)的疫苗市场。此前，CDC的建议是65岁以上的成年人和5岁以下的儿童接种肺炎球菌疫苗，同时建议某些免疫功能低下的群体接种。两家公司均请求CDC降低年龄建议至50岁以上的成年人。 这一建议得到了CDC主任曼迪·科恩的认可，她之前对肺炎球菌疫苗的指导主要集中在65岁以上的成年人和5岁以下的儿童。辉瑞和默沙东都希望这一变更能够增加他们的疫苗销售额。辉瑞的Prevnar是其最畅销的产品...
2024-10-24 15:15
B of A Securities Maintains Buy on Vaxcyte, Raises Price Target to $140
B of A Securities analyst Jason Gerberry maintains Vaxcyte (NASDAQ:PCVX) with a Buy and raises the price target from $101 to $140.
2024-09-04 19:34
Vaxcyte Starts $1 Billion Underwritten Public Offering
04:35 PM EDT, 09/03/2024 (MT Newswires) -- Vaxcyte (PCVX) said Tuesday it started a $1 billion underwritten public offering of common shares and pre-funded warrants. The company said it plans to give underwriters a 30-day option to buy up to an additional $150 million of common shares, including tho...
2024-09-04 04:35
Sector Update: Health Care Stocks Decline Late Afternoon
04:00 PM EDT, 09/03/2024 (MT Newswires) -- Health care stocks fell late Tuesday afternoon with the NYSE Health Care Index shedding 0.5% and the Health Care Select Sector SPDR Fund (XLV) down 0.3%. The iShares Biotechnology ETF (IBB) dropped 1.8%. In corporate news, TC BioPharm (TCBP) shares jumped 2...
2024-09-04 04:00
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) dipped 11.6% to $6.43. The company on Tuesday announced Phase 2 data for an investigational treatment for symptomatic Cerebral Cavernous Malformation (CCM). Nikola shares dipped 10.4% to $7.28 on Monday. Here are some other stocks moving in tod...
2024-09-04 01:41
Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Nasdaq Composite falling around 2% on Tuesday. Shares of Vaxcyte, Inc. (NASDAQ:PCVX) rose sharply during Tuesday's session after the company released topline results from the Phase 1/2 study evaluating the safety, tolerability and immunogenicity of VAX-31, the compan...
2024-09-03 22:47
Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher
Tuesday, Vaxcyte, Inc. (NASDAQ:PCVX) released topline results from the Phase 1/2 study evaluating the safety, tolerability and immunogenicity of VAX-31, the company's 31-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease. VAX-31 was well tolerated...
2024-09-03 21:40
Sector Update: Health Care Stocks Lean Lower Pre-Bell Tuesday
09:13 AM EDT, 09/03/2024 (MT Newswires) -- Health care stocks were leaning lower pre-bell Tuesday with the Health Care Select Sector SPDR Fund (XLV) down 0.1% and the iShares Biotechnology ETF (IBB) recently declining by 0.8%. Vaxcyte (PCVX) shares rose past 31% after it announced plans to launch by...
2024-09-03 21:13
